PTC Therapeutics, Inc. (PTCT)
68.69
-2.16
(-3.05%)
USD |
NASDAQ |
Apr 10, 16:00
68.74
+0.05
(+0.07%)
After-Hours: 20:00
PTC Therapeutics EPS Diluted (Quarterly) : -1.673 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Insmed, Inc. | -1.538 |
| Sarepta Therapeutics, Inc. | -3.934 |
| Keros Therapeutics, Inc. | -0.8626 |
| Madrigal Pharmaceuticals, Inc. | -2.566 |
| Protagonist Therapeutics, Inc. | -0.6932 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -134.96M |
| Revenue (Quarterly) | 164.68M |
| Total Expenses (Quarterly) | 299.64M |
| Enterprise Value | 4.139B |
| Gross Profit Margin (Quarterly) | 90.10% |
| Profit Margin (Quarterly) | -81.96% |
| Earnings Yield | 11.26% |
| Operating Earnings Yield | 15.01% |
| Normalized Earnings Yield | 11.13 |